Work

Flebogamma® 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases

Year: 2016

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Immunology

DOI: 10.1007/s10875-016-0303-4

Authors: Mark Ballow, Paul J. Pinciaro, Timothy Craig, Gary Kleiner, James Moy, Hans D. Ochs, John Sleasman, William Smits

Institutions: Women & Children's Hospital of Buffalo, University of South Florida, University of South Florida St. Petersburg, Grifols (United States), Penn State Milton S. Hershey Medical Center, University of Miami, Rush University Medical Center, University of Washington, Seattle Children's Research Institute

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: CSL Behring, Baxalta, BioCryst, Grifols

OpenAlex ID: W2415340552

FWCI: 0.404

Cites: 30

Cited by: 8

Related to: 10